ClinicalTrials.govpublic full text
Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer
estrogen receptor negative, her2/neu negative, progesterone receptor negative, recurrent breast carcinoma, stage iv breast cancer, triple-negative breast carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839128
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.